11/20
04:30 pm
cvrx
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
Medium
Report
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
11/4
12:44 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Craig Hallum from $15.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Craig Hallum from $15.00 to $20.00. They now have a "buy" rating on the stock.
11/4
08:00 am
cvrx
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
Low
Report
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
11/1
08:17 am
cvrx
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
Medium
Report
CVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]
10/30
03:35 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Lake Street Capital from $12.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Lake Street Capital from $12.00 to $15.00. They now have a "buy" rating on the stock.
10/30
02:16 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $15.00 to $17.00. They now have a "buy" rating on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $15.00 to $17.00. They now have a "buy" rating on the stock.
10/30
01:03 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $16.00 price target on the stock, up previously from $13.00.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $16.00 price target on the stock, up previously from $13.00.
10/29
04:05 pm
cvrx
CVRx Reports Third Quarter 2024 Financial and Operating Results
High
Report
CVRx Reports Third Quarter 2024 Financial and Operating Results
10/23
12:32 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $14.00 price target on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $14.00 price target on the stock.
10/20
07:30 am
cvrx
CVRx announces new CPT Category I codes for Barostim [Yahoo! Finance]
Medium
Report
CVRx announces new CPT Category I codes for Barostim [Yahoo! Finance]
10/18
02:10 pm
cvrx
CVRx announces new CPT® Category I codes for Barostim [Yahoo! Finance]
High
Report
CVRx announces new CPT® Category I codes for Barostim [Yahoo! Finance]
10/18
02:08 pm
cvrx
CVRx announces new CPT® Category I codes for Barostim
High
Report
CVRx announces new CPT® Category I codes for Barostim
10/15
04:30 pm
cvrx
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024
Medium
Report
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024
9/23
09:14 am
cvrx
Masimo (MASI) Surges 8.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Masimo (MASI) Surges 8.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
9/16
12:13 pm
cvrx
CVRX Stock Gains on Unveiling of Barostim's Positive Study Data [Yahoo! Finance]
Low
Report
CVRX Stock Gains on Unveiling of Barostim's Positive Study Data [Yahoo! Finance]
9/12
10:28 am
cvrx
CVRx touts positive two-year data for heart failure neuromodulation device [Yahoo! Finance]
Medium
Report
CVRx touts positive two-year data for heart failure neuromodulation device [Yahoo! Finance]
9/12
08:00 am
cvrx
CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
Medium
Report
CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
9/10
07:59 am
cvrx
CVRx, Inc. (NASDAQ: CVRX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $14.00 price target on the stock.
Low
Report
CVRx, Inc. (NASDAQ: CVRX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $14.00 price target on the stock.
9/3
08:30 am
cvrx
CVRx Announces Appointment of Two New Board Members
Medium
Report
CVRx Announces Appointment of Two New Board Members
8/26
02:07 pm
cvrx
CVRx, Inc. (NASDAQ: CVRX) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $12.00 price target on the stock.
Medium
Report
CVRx, Inc. (NASDAQ: CVRX) had its "buy" rating re-affirmed by analysts at Lake Street Capital. They now have a $12.00 price target on the stock.